Especially kidney transplant recipients have been investigated intensively: quantitative FOXP3 mRNA analysis linked elevated intragraft FOXP3 levels not only with acute cellular rejection (ACR)11–13, but also subclinical rejection14,15 and borderline changes16,17. This evidence concerns the gene FOXP3 and kidney transplant.